Kallikrein-binding protein is induced by growth hormone in the dwarf rat

FASEB Journal

Volumn 13, Issue 13, 1999, Pages 1839-1844

  Hatcher, Heather C ^a   Wright, Nancy M ^a   Chao, Julie ^a   Chao, Lee ^a   Ma, Jian Xing ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Growth hormone deficiency; Serpins; Tissue kallikrein

Indexed keywords

GROWTH HORMONE; KALLIKREIN; MESSENGER RNA;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DENSITOMETRY; DIABETIC RETINOPATHY; ENZYME LINKED IMMUNOSORBENT ASSAY; GROWTH; IMMUNOBLOTTING; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; RAT;

ANIMALIA;

EID: 0032873654     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fasebj.13.13.1839     Document Type: Article

References (40)

1. D'Ercole, A.J. (1987) Growth hormone action. In Serono Symposium Basic and Clinical Aspects of Growth Hormone (Bercu, B. B., ed) pp. 259-260, Plenum Press, New York
2. Kurtz, D. T., and Feigelson, P. (1977) Multihormonal induction of hepatic alpha2u-globulin mRNA as measured by hybridization to complementary DNA. Proc. Natl. Acad. Sci. USA 74, 4791-4795
3. Roy, A. K., Chatterjee, B., Demyan, N. F., Motwani, N., and Price, G. F. (1982) The endocrines and the liver. In Serono Symposium 51 (Langer, M., Chiandussi, L., Chopra, I. J., and Martini, L., eds) pp. 35-47, Academic Press, London
4. Chatterjee, B., Demyan, W. F., and Roy, A. K. (1983) Interacting role of thyroxin and growth hormone in the hepatic synthesis of alpha2i-globulin and its messenger RNA. J. Biol. Chem. 258, 688-692
5. Laperche, Y., Linch, K. R., Dolan, K. P., and Feigelson, P. (1983) Tissue-specific control of alpha 2u globulin gene expression: constitutive synthesis in the submaxillary gland. Cell 32, 453-460
6. Scott, C. D., Martin, J. L., and Baxter, R. C. (1985) Rat hepatocyte insulin-like growth factor I (IGF-I) and binding protein: effect of growth hormone in vitro and in vivo. Endocrinology 116, 1102-1107
7. Berry, S. A., and Seelig, S. (1984) Substantial induction of a new serum protein by growth hormone: physiochemical and physiological characterization. Endocrinology 115, 1164-1170
8. Yoon, J. B., Towle, H. C., and Seelig, S. (1987) Growth hormone induces two mRNA species of the serine proteinase inhibitor gene family in rat liver. J. Biol. Chem. 262, 4284-4289
9. Le Cam, A., Pages, G., Auberger, P., Le Cam, G., Leopold, P., Benarous, R., and Glaichenhaus, N. (1987) Study of a growth hormone-regulated protein secreted by rat hepatocytes: cDNA cloning, anti-protease activity and regulation of its synthesis by various hormones. EMBO J. 6, 1225-1232
10. Chao, J., Chai, K. X., Chen, L. M., Xiong, W., Chao, S., Woodley-Miller, C., Wang, L. X., Lu, H. S., and Chao, L. (1990) Tissue kallikrein-binding protein is a serpin. J. Biol. Chem. 265, 16394-16401
11. Chai, K. X., Ma, J. X., Murray, S. R., Chao, J., and Chao, L. (1991) Molecular cloning and analysis of the rat kallikrein-binding protein gene. J. Biol. Chem. 266, 16029-16036
12. Chao, J., and Chao, L. (1995) Biochemistry, regulation and potential function of kallistatin. Biol. Chem. Hoppe-Seyler 376, 705-713
13. Tecce, M. F., Dozin, B., Magnuson, M. A., and Nikodem, V. M. (1986) Transcriptional regulation by thyroid hormone of an mRNA homologous to a protease inhibitor. Biochemistry 25, 5831-5834
14. Yoon, J. B., Berry, S. A., Seelig, S., and Towle, H. C. (1990) An inducible nuclear factor binds to a growth hormone-regulated gene. J. Biol. Chem. 265, 19947-19954
15. Ma, J. X., Chao, J., and Chao, L. (1996) Identification and characterization of two promoters of rat kallikrein-binding protein gene. Biochim. Biophys. Acta 1307, 285-293
16. Chao, J., and Chao, L. (1988) A major difference of kallikrein-binding protein in spontaneously hypertensive versus normotensive rats. J. Hypertens. 6, 551-557
17. Ma, J. X., Yang, Z., Chao, J., and Chao, L. (1995) Intramuscular delivery of rat kallikrein-binding protein gene reverses hypotension in transgenic mice expressing human tissue kallikrein. J. Biol. Chem. 270, 451-455
18. Chen, L. M., Ma, J. X., Liang, Y. M., Chao, L., and Chao, J. (1996) Tissue kallikrein-binding protein reduces blood pressure in transgenic mice. J. Biol. Chem. 271, 27590-27594
19. Ma, J. X., King, L. P., Yang, Z., Crouch, R. K., Chao, L., and Chao, J. (1996) Kallistatin in human ocular tissues: reduced levels in vitreous fluids from patients with diabetic retinopathy. Curr. Eye Res. 15, 1117-1123
20. Hatcher, H. C., Ma, J. X., Chao, J., Chao, L., and Ottlecz, A. (1997) Kallikrein-binding protein levels are reduced in the retinas of streptozotocin-induced diabetic rats. IOVS 38, 658-664
21. Margolius, H. S. (1989) Tissue kallikreins and kinins: regulation and roles in hypertensive and diabetic diseases. Annu. Rev. Pharmacol. Toxicol. 29, 343-364
22. Mayfield, R. K., Margolius, H. S., Bailey, G. S., Miller, D. H., Sens, D. A., Squires, J., and Namm, D. H. (1985) Urinary and renal tissue kallikrein in the streptozotocin-diabetic rat. Diabetes 34, 22-28
23. Ma, J. X., Song, Q., Hatcher, H. C., Crouch, R. K., Chao, L., and Chao, J. (1996) Expression and cellular localization of the kallikrein-kinin system in human ocular tissues. Exp. Eye Res. 63, 19-26
24. Sinha, Y. N., Baxter, S. R., Larson, B. A., and Vanderlaan, W. P. (1979) Levels of prolactin, growth hormone and insulin in genetically diabetic (db/db) mice. Proc. Soc. Exp. Biol. Med. 161, 78-81
25. Tannenbaum, G. S. (1981) Growth hormone secretory dynamics in streptozotocin diabetes: evidence of a role for endogenous circulating somatostatin. Endocrinology 108, 76-78
26. Maes, M., Ketelslegers, J. M., and Underwood, L. E. (1983) Low plasma somatomedin-C in streptozotocin-induced diabetes mellitus: correlation with changes in somatogenic and lactogenic liver binding sites. Diabetes 32, 1060-1069
27. Bluet-Pajot, M. T., Durand, D., and Kordon, C. (1983) Influence of streptozotocin-induced diabetes on growth hormone secretion in the rat. Neuroendocrinology 36, 307-309
28. Charlton, H. M., Clark, R. G., Robinson, I. C., Goff, A. E., Cox, B. S., Bugnon, C., and Bloch, B. A. (1988) Growth hormone-deficient dwarfism in the rat: a new mutation. J. Endocrinol. 119, 51-58
29. Wright, N. M., Renault, J., Hollis, B., Bell, N. H., and Key, L. L. (1995) Effect of growth hormone on bone: bone mineral density, trabecular bone volume, and alkaline phosphatase improve or are restored in the dwarf rat treated with growth hormone. J. Bone Miner. Res. 10, 127-131
30. Chen, L. M., Song, Q., Chao, L., and Chao, J. (1995) Cellular localization of tissue kallikrein and kallistatin mRNAs in human kidney. Kidney Int. 48, 690-697
31. Guesdon, J. L., Ternyck, T., and Avrameas, S. (1979) The use of avidin-biotin interaction in immunoenzymatic techniques. J. Histochem. Cytochem. 27, 1131-1139
32. Chao, S., Chao, L., and Chao, J. (1989) Enhanced specificity in immunoscreening of expression cDNA clones using radiolabeled antigen overlay. BioTechniques 7, 68-72
33. Bhoola, K. D., Figueroa, C. D., and Worthy, K. (1992) Bioregulation of kinins: kallikreins, kininogens, and kininases. Pharmacol. Rev. 44, 1-80
34. Zhou, G., Chao, L., and Chao, J. (1992) Kallistatin: a novel human tissue kallikrein inhibitor. J. Biol. Chem. 267, 25873-25880
35. Xiong, W., Tang, C. Q., Zhou, G. X., Chao, L., and Chao, J. (1992) In vivo catabolism of human kallikrein-binding protein and its complex with tissue kallikrein. Tohoku J. Exp Med. 171, 135-144
36. Jaffa, A. A., Chai, K. X., Chao, J., Chao, L., and Mayfield, R. K. (1992) Effects of diabetes and insulin on expression of kallikrein and renin genes in the kidney. Kidney Int. 41, 789-795
37. Handa, H., Skurama, S., Nakagawa, S., Yasukouchi, T., Skamoto, W., and Izumi, H. (1989) Glandular kallikrein, renin, and angiotensin converting enzyme of diabetic and hypertensive rats. Adv. Exp. Med. Biol. 247, 443-448
38. Harvey, J. N., Edmundson, A. W., Jaffa, A. A., Martin, L. L., and Mayfield, R. K. (1992) Renal excretion of kallikrein and eicosanoids in patients with Type I (insulin-dependent) diabetes mellitus. Relationship to glomerular and tubular function. Diabetologia 35, 857-862
39. Donahue, L. R., Beamer, W. G. (1993) Growth hormone deficiency in 'little' mice results in aberrant body composition, reduced insulin-like growth factor-1 and insulin-like growth factor binding protein-3. J. Endocrinol. 136, 91-104
40. Russell-Jones, D. L., Weissberger, A. J., Bowes S. B., Kelly, J. M., Thomason, M., Umpleby, A. M., Jones, R. H., and Sönksen, P. H. (1993) Protein metabolism in growth hormone deficiency, and effects of growth hormone replacement therapy. Acta Endocrinol. 128, Suppl. 2, 44-47